Detection of EGFR mutations in plasma cfDNA and paired CTCs of NSCLC patients before and after osimertinib therapy using crystal digital PCR

被引：0
|
作者：
Ntzifa, Aliki [1 ]
Kotsakis, Athanasios [2 ]
Georgoulias, Vassilis [3 ]
Lianidou, Evi [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Athens, Greece
[2] Gen Univ Hosp Larissa, Larisa, Greece
[3] Hellen Oncol Res Grp HORG, Athens, Greece
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5158
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Detection of CK-19 mRNA positive CTCs, isolated with a size -based microfluidics platform, in NSCLC patients under osimertinib therapy
    Ntzifa, Aliki
    Kotsakis, Athanasios
    Georgoulias, Vassilis
    Lianidou, Evi
    CANCER RESEARCH, 2019, 79 (13)
  • [32] Plasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimertinib
    Ding, Pei N.
    Becker, Therese
    Bray, Victoria
    Chua, Wei
    Ma, Yafeng
    Xu, Bo
    Lynch, David
    de Souza, Paul
    Roberts, Tara
    THORACIC CANCER, 2019, 10 (10) : 1879 - 1884
  • [33] EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR
    Anna Buder
    Ulrike Setinek
    Maximilian J. Hochmair
    Sophia Schwab
    Klaus Kirchbacher
    Andrea Keck
    Otto C. Burghuber
    Robert Pirker
    Martin Filipits
    Targeted Oncology, 2019, 14 : 197 - 203
  • [34] A Historical Comparison of Patients with Advanced NSCLC Harboring Uncommon EGFR Mutations Before and After the Approval of Afatinib in Japan
    Kawamura, T.
    Murakami, H.
    Kobayashi, H.
    Nakashima, K.
    Omori, S.
    Wakuda, K.
    Ono, A.
    Kenmotsu, H.
    Naito, T.
    Endo, M.
    Takahashi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S888 - S888
  • [35] EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR
    Buder, Anna
    Setinek, Ulrike
    Hochmair, Maximilian J.
    Schwab, Sophia
    Kirchbacher, Klaus
    Keck, Andrea
    Burghuber, Otto C.
    Pirker, Robert
    Filipits, Martin
    TARGETED ONCOLOGY, 2019, 14 (02) : 197 - 203
  • [36] Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples
    Ishii, Hidenobu
    Azuma, Koichi
    Sakai, Kazuko
    Kawahara, Akihiko
    Yamada, Kazuhiko
    Tokito, Takaaki
    Okamoto, Isamu
    Nishio, Kazuto
    Hoshino, Tomoaki
    ONCOTARGET, 2015, 6 (31) : 30850 - 30858
  • [37] Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC
    Chen, Xuejing
    Li, Kun
    Liu, Zichen
    Gai, Fei
    Zhu, Guanshan
    Lu, Shun
    Che, Nanying
    CANCER MEDICINE, 2021, 10 (07): : 2286 - 2292
  • [38] Detection of EGFR mutations in patients with suspected lung cancer using paired tissue-plasma testing: a prospective comparative study with plasma ddPCR assay
    Shong, Lynn Yim-Wah
    Deng, Jun-Yang
    Kwok, Hoi-Hin
    Lee, Nerissa Chui-Mei
    Tseng, Steven Cee-Zhung
    Ng, Lai-Yun
    Yee, Wilson Kwok-Sang
    Lam, David Chi-Leung
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [39] Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR
    Ryohei Yoshida
    Takaaki Sasaki
    Yasuhiro Umekage
    Sachie Tanno
    Yusuke Ono
    Munehiko Ogata
    Shinichi Chiba
    Yusuke Mizukami
    Yoshinobu Ohsaki
    BMC Cancer, 18
  • [40] Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR
    Yoshida, Ryohei
    Sasaki, Takaaki
    Umekage, Yasuhiro
    Tanno, Sachie
    Ono, Yusuke
    Ogata, Munehiko
    Chiba, Shinichi
    Mizukami, Yusuke
    Ohsaki, Yoshinobu
    BMC CANCER, 2018, 18
12345